LIGHTPOINT MEDICAL LTD. COMPANY HAS CREATED AN INNOVATIVE DEVICE FOR CANCER SURGERY
Detection and radical treatment of cancer at the early stages is the key to patient survival. In addition to radiotherapy and chemotherapy, surgery occupies key role in the treatment. Despite the planning of operations and compliance with all antiblastic rules, sometimes surgeons cannot remove all cancer cells. Consequently, after some time, patients need to repeat operative interventions.
In aid of patients and surgeons, Lightpoint Medical Ltd. in partnership with a development team of Sagentia company created LightPath ™ Imaging System device – the first system in the world which represents molecular structure of tissues affected by tumor. This apparatus is created for using straight during surgery and is able to determine completeness of the removal of tumor cells in real time.
The meaning of system work method is to detect Cherenkov elementary particles, in other words, extremely low radiation generated by positron emission tomography (PET). Before surgery, the patient is given radioactive elementary particles that accumulate in cancer cells. In this way, LightPath ™ Imaging System allows the surgeon to identify the prevalence of pathological cells during surgery.
Sagentia and Lightpoint Medical Ltd. Companies jointly studied implementation methods of this technology in surgery. Owing to the developers of the companies and implementation of this technology in cancer surgery, it’s possible to reduce the number of cancer recurrences and increase the quality of surgical interventions.
Despite considerable scientific breakthrough of LightPath ™ Imaging System, its main disadvantage is high cost of common maintenance and implementation.
24.08.2016